Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study

BACKGROUND: To evaluate the efficacy, safety and health economics of sequential everolimus in treating angiomyolipoma (AML) associated with tuberous sclerosis complex (TSC). METHODS: In this prospective cohort study, patients met the inclusion criteria received standard or sequential treatment accor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Liangyou, Peng, Cheng, Zhang, Fan, Fang, Cunjin, Guo, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201725/
https://www.ncbi.nlm.nih.gov/pubmed/34127034
http://dx.doi.org/10.1186/s13023-021-01913-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201725/
https://www.ncbi.nlm.nih.gov/pubmed/34127034
http://dx.doi.org/10.1186/s13023-021-01913-2

Ejemplares similares